BlackRock »

Prelude Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.2M 1.1M 4.74
2023-09-30 $3.3M 1.1M 3.09
2023-06-30 $3.9M 859k 4.50
2023-03-31 $2.4M 423k 5.70
2022-12-31 $2.4M 394k 6.04
2022-06-30 $2.8M 529k 5.24
2021-06-30 $20M 703k 28.71
2021-03-31 $30M 682k 43.32
2020-12-31 $46M 637k 71.53
2020-09-30 $1.9M 63k 30.06